Nutriband Inc

+0.34 (+8.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)33.26M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.53 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$4.00
50-Day MA$4.00
200-Day MAN/A
See more pivots

Nutriband Inc Stock, NASDAQ:NTRB

121 South Orange Avenue, Suite 1500, Orlando, Florida 32801
United States of America
Phone: +1.407.377.6695
Number of Employees: 13


Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It delivers abuse deterrent fentanyl transdermal system which provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. It operates through the Pocono Coated Products and Active Intelligence segments. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.